SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-253555
Filing Date
2023-10-10
Accepted
2023-10-10 17:17:59
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A d540258ddefm14a.htm DEFM14A 3706675
2 GRAPHIC g540258g02z05.jpg GRAPHIC 61236
3 GRAPHIC g540258g03g42.jpg GRAPHIC 50040
4 GRAPHIC g540258g03m39.jpg GRAPHIC 24379
5 GRAPHIC g540258g23m01.jpg GRAPHIC 401197
6 GRAPHIC g540258g23m02.jpg GRAPHIC 367204
7 GRAPHIC g540258g54e66.jpg GRAPHIC 196838
8 GRAPHIC g540258g58q60.jpg GRAPHIC 79732
9 GRAPHIC g540258g89o75.jpg GRAPHIC 98619
  Complete submission text file 0001193125-23-253555.txt   5465875
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33004 | Film No.: 231318769
SIC: 2834 Pharmaceutical Preparations